Evaluation the antioxidant effect of chromium picolinate in doxorubicin induced cardiotoxicity in a rat model

Abstract

Doxorubicin (DOX) is a potent antineoplastic drug used to treat many types of human tumor. The long-term adverse effect is cardiomyopathy. Chromium is an essential trace element mostly used to regulate glucose levels and enhance the response to insulin, especially in diabetes. Current study aimed to evaluate the cardioprotective effect of chromium picolinate against doxorubicin-induced cardiotoxicity in 28 male rats divided into four groups. Group I (Control group): received distilled water orally for 8 days. Group II (Doxorubicin group): received distilled water orally for 7 days, followed by a single doxorubicin dose (25 mg/kg) intraperitoneally. Group III (Chromium 2 mg): received chromium picolinate at a dose (2 mg /kg) orally for 7 days, followed by a single doxorubicin dose (25 mg/kg) intraperitoneally. Group IV (Chromium 4 mg): received chromium picolinate at a dose (4 mg /kg) orally for 7 days, followed by a single doxorubicin dose (25 mg/kg) intraperitoneally. Levels of lactate dehydrogenase (LDH) and serum troponin were assessed in the sera of all groups by ELISA technique while the cardiac homogenate used to assess malondialdehyde (MDA) by ELISA technique and superoxide dismutase (SOD) by RT-qPCR method and the results indicated that the co- administration of chromium picolinate at dose (2mg/kg) and (4mg/kg) caused a significant decrease in cardiac LDH and MDA and significant elevation in SOD level in groups III and IV compared to group II This current research indicated that Chromium picolinate have a potential role in reducing cardiac injury and oxidative stress in patients treated with doxorubicin.

Keywords

• Cardiotoxicity
• chromium picolinate
• lactate dehydrogenase
• superoxide dismutase
• serum troponin

References

1. Wouters KA, Kremer LCM, Miller TL, Herman EH, Lipshultz SE. Protecting against anthracycline-induced myocardial damage: A review of the most promising strategies. Br J Haematol. 2005;131(5):561–578. https://doi.org/10.1111/j.1365-2141.2005.05759.x
2. (Vitamin E and C) Against the Toxicity of Doxorubicin in Breast Cancer Patients. J Fac Med Baghdad. 2009;51(1):95– 100. https://doi.org/10.32007/jfacmedbagdad.5111190
3. Venditti P, Balestrieri M, De Leo T, Di Meo S. Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres. Cardiovasc Res. 1998;38(3):695–702. https://doi.org/10.1016/s0008- 6363(98)00034-0
4. Clayton ZS, Brunt VE, Hutton DA, VanDongen NS, D'Alessandro A, Reisz JA, Ziemba BP, Seals DR. Doxorubicin- Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment. JACC CardioOncol. 2020;2(3):475-488. https://doi.org/10.1016/j.jaccao.2020.06.010
5. Jungsuwadee P. Doxorubicin-induced cardiomyopathy: an update beyond oxidative stress and myocardial cell death. Cardiovasc Regen Med. 2016; 3: e1127. http://dx.doi.org/10.14800/crm.1127
6. Fox CA, Romenskaia I, Dagda RK, Ryan RO. Cardiolipin nanodisks confer protection against doxorubicin-induced mitochondrial dysfunction. Biochim Biophys Acta Biomembr. 2022;1864(10):183984. https://doi.org/10.1016/j.bbamem.2022.183984
7. Anderson RA. Chromium and insulin resistance. Nutr Res Rev. 2003;16(2):267-275. https://doi.org/10.1079/nrr200366
8. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33(7):503-510. https://doi.org/10.1021/ar990073r

9. Volek JS, Silvestre R, Kirwan JP, Sharman MJ, Judelson DA, Spiering BA, Vingren JL, Maresh CM, Vanheest JL, Kraemer WJ. Effects of chromium supplementation on glycogen synthesis after high-intensity exercise. Med Sci Sports Exerc. 2006;38(12):2102-2109. https://doi.org/10.1249/01.mss.0000235353.09061.54
10. Al-Rasheed NM, Attia HA, Mohamed RA, Al-Rasheed NM, Al-Amin MA. Preventive effects of selenium yeast, chromium picolinate, zinc sulfate and their combination on oxidative stress, inflammation, impaired angiogenesis and atherogenesis in myocardial infarction in rats. J Pharm Pharm Sci. 2013;16(5):848-687. https://doi.org/10.18433/j34c7n
11. Dubey VK, Ansari F, Vohora D, Khanam R. Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats. J Trace Elem Med Biol [Internet]. 2015;29:222–226. http://dx.doi.org/10.1016/j.jtemb.2014.06.014.
12. Chen J, Kan M, Ratnasekera P, Deol LK, Thakkar V, Davison KM. Blood Chromium Levels and Their Association with Cardiovascular Diseases, Diabetes, and Depression: National Health and Nutrition Examination Survey (NHANES) 2015-2016. Nutrients. 2022;14(13):2687. https://doi.org/10.3390/nu14132687
13. Abdul Ridha DK, Al-Shawi NN. Impacts of Graded Doses of Pyridoxine on the Biomarkers, Aspartate Aminotransferase, lactate Dehydrogenase and Total Antioxidant Capacity in Doxorubicin-Induced Cardiotoxicity in Female Rats. Iraqi J Pharm Sci. 2017;26(2):12–21. https://doi.org/10.31351/vol26iss2pp12-21
14. Aziz MM, Abd El Fattah MA, Ahmed KA, Sayed HM. Protective effects of olmesartan and l-carnitine on doxorubicin- induced cardiotoxicity in rats. Can J Physiol Pharmacol. 2020;98(4):183-193. https://doi.org/10.1139/cjpp-2019-0299
15. Lin L, Sylvén C, Sotonyi P, Somogyi E, Kaijser L, Jansson E. Lactate dehydrogenase and its isoenzyme activities in different parts of the normal human heart. Cardiovasc Res. 1989;23(7):601-606. https://doi.org/10.1093/cvr/23.7.601
16. Gabriel-Costa D, da Cunha TF, Bechara LR, Fortunato RS, Bozi LH, Coelho Mde A, Barreto-Chaves ML, Brum PC. Lactate up-regulates the expression of lactate oxidation complex-related genes in left ventricular cardiac tissue of rats. PLoS One. 2015;10(5):e0127843. https://doi.org/10.1371/journal.pone.0127843
17. Fadhel MH, Hassan AF. Effects of Omega-7 on Oxidative Stress in Doxorubicin-Treated Cardiac Tissue. Iraqi J Pharm Sci. 2023;32(3):35–40. https://doi.org/10.31351/vol32iss3pp35-40
18. Abdel-Hady EA. Chromium picolinate supplementation improves cardiac performance in hypoxic rats. Acta Cardiol. 2024;79(3):387-397. https://doi.org/10.1080/00015385.2022.2041782
19. Bannister C, Tam To B, Patel T, Yap R, Cannata A, Bromage D, Mcdonagh T. The use of high sensitivity troponin T as a biomarker of anthracycline cardiotoxicity. Eur Heart J. 2023;44(Supplement_2): ehad655.2718. http://dx.doi.org/10.1093/eurheartj/ehad655.2718
20. Bertinchant JP, Polge A, Juan JM, Oliva-Lauraire MC, Giuliani I, Marty-Double C, Burdy JY, Fabbro-Peray P, Laprade M, Bali JP, Granier C, de la Coussaye JE, Dauzat M. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings. Clin Chim Acta. 2003;329(1-2):39-51. https://doi.org/10.1016/s0009-8981(03)00013-5
21. Thonusin C, Osataphan N, Leemasawat K, Nawara W, Sriwichaiin S, Supakham S, Gunaparn S, Apaijai N, Somwangprasert A, Phrommintikul A, Chattipakorn SC, Chattipakorn N. Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients. J Transl Med. 2024;22(1):398. https://doi.org/10.1186/s12967-024-05088-9.
22. Cırrık S, Kabartan E, Hacıoğlu G, Güleç Peker EG. The Effects of Prunus Laurocerasus Fruit Extract on Oxidative and Endoplasmic Reticulum Stress Responses in Doxorubicin-induced Cardiac Damage. J Acad Res Med. 2024;14(1):34– 39. https://doi.org/10.4274/jarem.galenos.2024.27676
23. Khalaf QH, Awad NAN, Hamadie SS. A study evaluating the relationship between chromium level and myocardial infarction. J Cardiovasc Dis Res. 2021; 12(3):535-540.
24. Abebe W, Liu JY, Wimborne H, Mozaffari MS. Effects of chromium picolinate on vascular reactivity and cardiac ischemia-reperfusion injury in spontaneously hypertensive rats. Pharmacol Rep. 2010;62(4):674-682. https://doi.org/10.1016%2Fs1734-1140(10)70324-8
25. Naderi Y, Khosraviani S, Nasiri S, Hajiaghaei F, Aali E, Jamialahmadi T, Banach M, Sahebkar A. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 2023;158:114055. https://doi.org/10.1016/j.biopha.2022.114055.
26. Akpinar D, Mercan T, Demir H, Ozdemir S, Demir C, Kavak S. Protective Effects of Thymoquinone on Doxorubicin- induced Lipid Peroxidation and Antioxidant Enzyme Levels in Rat Peripheral Tissues. Pak Vet J. 2023;43(4):651–658. http://dx.doi.org/10.29261/pakvetj/2023.070
27. Li J, Luo T, Zhao Y, Wang D, Jin Y, Wu Z, Yang G, Qi X. Cardioprotective potentials of myricetin on doxorubicin- induced cardiotoxicity based on biochemical and transcriptomic analysis. Biomed Pharmacother. 2024;175:116748. https://doi.org/10.1016/j.biopha.2024.116748.
28. Shekari M, Gortany NK, Khalilzadeh M, Abdollahi A, Ghafari H, Dehpour AR, Ghazi-Khansari M. Cardioprotective effects of sodium thiosulfate against doxorubicin-induced cardiotoxicity in male rats. BMC Pharmacol Toxicol. 2022;23(1):32. https://doi.org/10.1186/s40360-022-00569-3
29. Sadek KM, Mahmoud SFE, Zeweil MF, Abouzed TK. Proanthocyanidin alleviates doxorubicin-induced cardiac injury by inhibiting NF-kB pathway and modulating oxidative stress, cell cycle, and fibrogenesis. J Biochem Mol Toxicol. 2021;35(4):e22716. https://doi.org/10.1002/jbt.22716
30. Wang W, Zhong X, Fang Z, Li J, Li H, Liu X, Yuan X, Huang W, Huang Z. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway. Chem Biol Interact. 2023 ;377:110469. https://doi.org/10.1016/j.cbi.2023.110469.
31. Gossa Al-Saadde DL, Haider AM, Ali A, Abdu Musad Saleh E, Turki Jalil A, Abdulelah FM, Romero-Parra RM, Tayyib NA, Ramírez-Coronel AA, Alkhayyat AS. The role of chromium supplementation in cardiovascular risk factors: A comprehensive reviews of putative molecular mechanisms. Heliyon. 2023;9(9):e19826. https://doi.org/10.1016/j.heliyon.2023.e19826
32. Liu Y, Wang D. Administration of chromium(III) and manganese(II) as a potential protective approach against daunorubicin-induced cardiotoxicity: in vitro and in vivo experimental evidence. Biol Trace Elem Res. 2013;156(1- 3):253-261.
33. Simonoff M. Chromium deficiency and cardiovascular risk. Cardiovasc Res. 1984;18(10):591-596. https://doi.org/10.1093/cvr/18.10.591
34. Ahmed AZ, Satyam SM, Shetty P, D'Souza MR. Methyl Gallate Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Suppressing Oxidative Stress. Scientifica (Cairo). 2021;2021:6694340. https://doi.org/10.1155/2021/6694340
35. VIDT DG, BREDEMEYER A, SAPIRSTEIN E, SAPIRSTEIN LA. Effect of ether anesthesia on the cardiac output, blood pressure, and distribution of blood flow in the albino rat. Circ Res. 1959;7:759-764. https://doi.org/10.1161/01.res.7.5.759
36. Hameed HA, Hassan AF. The Prophylactic Anti-Inflammatory Effect of Omega-7 Against Paracetamol- Induced Liver Injury in Rats. 2022; 46(2), 43-47. https://doi.org/10.30539/ijvm.v46i2.1412
37. Hashim Mohammed Y, Hassan AF. Analyzing the Potential Antioxidative Effects of Omega-369 in Preventing AcetaminophenInduced Liver Damage. Al-Rafidain J Med Sci. 2023;4:73–78. https://doi.org/10.54133/ajms.v4i.126
38. Mahmood S, Hassan A. The Anti-Inflammatory Effect of Omega-7 Against Cisplatin in Rat Model. Iraqi J Vet Med. 2022;46(2):48–52. http://dx.doi.org/10.30539/ijvm.v46i2.1413
39. Abd MR, Hassan AF. The Ameliorative Effect of Fimasartan against Methotrexate-Induced Nephrotoxicity in Rats. Iraqi J Pharm Sci. 2022;31(1):87–94. https://doi.org/10.31351/vol31iss1pp87-94
40. Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, Morimoto S. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J Nat Med. 2018;72(1):32-42. https://doi.org/10.1007/s11418-017-1144-z.
41. Lampl T, Crum JA, Davis TA, Milligan C, Del Gaizo Moore V. Isolation and functional analysis of mitochondria from cultured cells and mouse tissue. J Vis Exp. 2015;(97):52076. https://doi.org/10.3791/52076
42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. https://doi.org/10.1006/meth.2001.1262
43. Mahmood YS, Kadhim SH. Protective Effects of Citronellol Against Rhabdomyolysis-Induced Acute Kidney Injury in Mice by Inhibiting NF-κB and IL-1β Signaling Pathway. Iraqi J Pharm Sci. 2023;32:85–90. https://doi.org/10.31351/vol32issSuppl.pp85-90 Jabur MS, Manna MJ, Mohammad HR, Baqir LS, Abdulamir HA. Ocular Hypotensive Effect for the Topical Amlodipine 0.5% Eye Drop. Lat Am J Pharm. 2023;42 (special issue): 311-314.
44. Al-Shammari AH, Ali Shahadha MA. The effect of Favipiravir on liver enzyme among patients with mild to moderate COVID-19 infection: A prospective cohort study. J Popul Ther Clin Pharmacol. 2022 ;29(4):e46-e54. https://doi.org/10.15586/jptcp.2022.967